Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Phase 2
Active, not recruiting
- Conditions
- Long COVIDPost Acute Sequelae of COVID-19Post-Acute COVID-19
- Interventions
- Other: Placebo
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Timothy Henrich
- Target Recruit Count
- 40
- Registration Number
- NCT06161688
- Locations
- 🇺🇸
UCSF/Zuckerberg San Francisco General Hospital, San Francisco, California, United States
News
No news found